A new Oncotarget interview with Dr. El-Deiry and a former MD/PhD student in his lab on the paper: "TRAIL receptor agonists convert the response of #breastcancer cells to ONC201 from anti-proliferative to apoptotic." https://youtu.be/nyw1AQl72O4 #eldeirylab